IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 133 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $60,815 | -24.0% | 13,366 | +17.6% | 0.00% | -25.0% |
Q2 2023 | $80,038 | +37.4% | 11,369 | +24.7% | 0.00% | +33.3% |
Q4 2022 | $58,270 | -33.3% | 9,119 | 0.0% | 0.00% | -25.0% |
Q3 2022 | $87,360 | -13.2% | 9,119 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $100,674 | +3.8% | 9,119 | +79.4% | 0.00% | +300.0% |
Q4 2021 | $97,015 | -21.9% | 5,082 | +0.8% | 0.00% | -50.0% |
Q3 2021 | $124,286 | -60.8% | 5,040 | -49.7% | 0.00% | -60.0% |
Q1 2021 | $317,012 | -34.7% | 10,013 | -4.3% | 0.01% | -28.6% |
Q4 2020 | $485,530 | +38.3% | 10,464 | -1.9% | 0.01% | +16.7% |
Q3 2020 | $351,191 | +19.1% | 10,668 | -0.7% | 0.01% | +20.0% |
Q2 2020 | $294,950 | -72.2% | 10,745 | -69.7% | 0.01% | -78.3% |
Q1 2020 | $1,061,615 | +4.9% | 35,464 | -3.0% | 0.02% | +35.3% |
Q4 2019 | $1,011,925 | +49.3% | 36,558 | -1.8% | 0.02% | +54.5% |
Q3 2019 | $677,768 | -21.9% | 37,240 | +5.2% | 0.01% | -26.7% |
Q2 2019 | $867,640 | +157.8% | 35,385 | 0.0% | 0.02% | +150.0% |
Q1 2019 | $336,511 | +7.5% | 35,385 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $313,157 | +1.7% | 35,385 | +29.3% | 0.01% | +20.0% |
Q3 2018 | $307,969 | – | 27,375 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |